T1	Participants 102 116	mild pneumonia
T2	Participants 263 402	Eighty-six male patients, doing their obligatory military service, ranging between 19 and 24 years of age (mean 20), were randomly treated:
T3	Participants 579 641	Seventy-eight patients were able to be evaluated for efficacy,
